• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌合并心包转移。

Nasopharyngeal carcinoma with pericardial metastasis.

机构信息

Division of Hemato-Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Liouying, Tainan, Taiwan.

出版信息

Kaohsiung J Med Sci. 2011 Jul;27(7):289-91. doi: 10.1016/j.kjms.2010.08.005. Epub 2011 Apr 17.

DOI:10.1016/j.kjms.2010.08.005
PMID:21757147
Abstract

Nasopharyngeal carcinoma (NPC) is prevalent in Taiwan and is characterized by a high frequency of nodal metastasis. The most common organs with distal metastases are the bones, lungs, and liver, with extremely rare cases to the pericardium. Herein, we report a rare case with NPC who presented with dyspnea and orthopnea. Serial studies, including pericardial biopsy, revealed NPC with pericardial metastasis and pericardial effusion. The tumor cells of both the original and metastatic tumors were positive for Epstein-Barr virus by in situ hybridization. This is the first histologically confirmed case of NPC with pericardial metastasis.

摘要

鼻咽癌(NPC)在台湾地区较为常见,其特征是淋巴结转移率较高。远处转移最常见的器官是骨骼、肺部和肝脏,极罕见转移至心包。本文报告 1 例罕见的 NPC 患者,以呼吸困难和端坐呼吸为主要表现。连续的研究,包括心包活检,提示 NPC 合并心包转移和心包积液。原位杂交显示原发和转移肿瘤的肿瘤细胞均为 EBV 阳性。这是首例经组织学证实的 NPC 合并心包转移病例。

相似文献

1
Nasopharyngeal carcinoma with pericardial metastasis.鼻咽癌合并心包转移。
Kaohsiung J Med Sci. 2011 Jul;27(7):289-91. doi: 10.1016/j.kjms.2010.08.005. Epub 2011 Apr 17.
2
[Analysis of Epstein-Barr virus BamH I "f" variant in nodal metastasis of nasopharyngeal carcinoma].[鼻咽癌淋巴结转移中爱泼斯坦-巴尔病毒BamH I “f” 变异体的分析]
Zhonghua Bing Li Xue Za Zhi. 2008 Mar;37(3):160-4.
3
Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.整合模型纳入转移性区域颈淋巴结体积和治疗前血清爱泼斯坦-巴尔病毒DNA拷贝数在预测N1期鼻咽癌患者远处转移中的预后价值
Chin J Cancer. 2017 Dec 29;36(1):98. doi: 10.1186/s40880-017-0264-x.
4
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.鼻咽癌患者鼻咽刷检物中爱泼斯坦-巴尔病毒mRNA谱和病毒DNA甲基化状态反映肿瘤起源。
Int J Cancer. 2017 Jan 1;140(1):149-162. doi: 10.1002/ijc.30418. Epub 2016 Sep 23.
5
Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma.在鼻咽癌及原发性不明癌患者转移性淋巴结中检测爱泼斯坦-巴尔病毒。
Arch Otolaryngol Head Neck Surg. 2003 Mar;129(3):338-40. doi: 10.1001/archotol.129.3.338.
6
Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.LINC00312 的表达与鼻咽癌的肿瘤大小呈负相关,与淋巴结转移呈正相关。LINC00312 是一种长的基因间非编码 RNA。
J Mol Histol. 2013 Oct;44(5):545-54. doi: 10.1007/s10735-013-9503-x. Epub 2013 Mar 26.
7
Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.疑似鼻咽癌患者鼻咽组织中爱泼斯坦-巴尔病毒的检测
Cancer. 1998 Apr 15;82(8):1449-53.
8
Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.内源性酪氨酸激酶受体在 Epstein-Barr 病毒相关的鼻咽癌及其转移中的作用。
Am J Pathol. 2012 Nov;181(5):1773-81. doi: 10.1016/j.ajpath.2012.07.014. Epub 2012 Sep 11.
9
Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.EB 病毒编码 RNA 作为鼻咽癌的生存预测指标。
Chin Med J (Engl). 2014;127(2):294-9.
10
Diagnostic utility of immunohistochemical analysis and Epstein-Barr virus-encoded small RNAs in situ hybridisation of cell block sections obtained using fine-needle aspiration in nasopharyngeal carcinoma with lymph node metastasis.免疫组织化学分析及爱泼斯坦-巴尔病毒编码小RNA原位杂交技术在经细针穿刺获取的鼻咽癌伴淋巴结转移细胞块切片中的诊断效用
Diagn Cytopathol. 2019 Mar;47(3):200-205. doi: 10.1002/dc.24074. Epub 2018 Dec 28.

引用本文的文献

1
Anti-PD-1 Therapy-A Potential Treatment for Myocardial Metastasis From Nasopharyngeal Carcinoma: A Case Report.抗 PD-1 治疗——鼻咽癌心肌转移的潜在治疗方法:一例报告。
Front Immunol. 2021 Nov 5;12:688682. doi: 10.3389/fimmu.2021.688682. eCollection 2021.
2
CYFRA21-1/TG ratio as an accurate risk factor to predict eye metastasis in nasopharyngeal carcinoma: A STROBE-compliant article.CYFRA21-1/TG比值作为预测鼻咽癌眼转移的准确风险因素:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2020 Nov 13;99(46):e22773. doi: 10.1097/MD.0000000000022773.

本文引用的文献

1
Pericardial metastases in a long-surviving patient with sigmoid carcinoma.一名长期存活的乙状结肠癌患者出现心包转移。
Tumori. 2005 Jan-Feb;91(1):101-2. doi: 10.1177/030089160509100122.
2
Prognostic factors affecting the outcome of nasopharyngeal carcinoma.
Jpn J Clin Oncol. 2003 Oct;33(10):501-8. doi: 10.1093/jjco/hyg092.
3
Squamous cell carcinoma of the buccal mucosa with metastases to the pericardial cavity, lung and thyroid.颊黏膜鳞状细胞癌伴心包腔、肺和甲状腺转移。
Oral Oncol. 2002 Jan;38(1):114-6. doi: 10.1016/s1368-8375(01)00021-5.
4
Pericardial metastasis in carcinoma of the uterine cervix.子宫颈癌的心包转移
Gynecol Oncol. 1996 Jun;61(3):451-3. doi: 10.1006/gyno.1996.0174.
5
Nasopharyngeal carcinoma with cardiac tamponade.鼻咽癌伴心脏压塞
Am J Otolaryngol. 1994 Jul-Aug;15(4):307-9. doi: 10.1016/0196-0709(94)90102-3.
6
Malignant pericardial effusion as initial solitary site of metastasis from transitional cell carcinoma of the bladder.
Urology. 1995 Feb;45(2):320-2. doi: 10.1016/0090-4295(95)80025-5.
7
Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients.
J Surg Oncol. 1986 Nov;33(3):194-7. doi: 10.1002/jso.2930330310.
8
The incidence of secondary tumors of the heart and pericardium: a 10-year study.心脏和心包继发性肿瘤的发病率:一项为期10年的研究。
Jpn J Clin Oncol. 1988 Sep;18(3):195-201.
9
Clinical features and management of distant metastases of nasopharyngeal carcinoma.鼻咽癌远处转移的临床特征与治疗
J Otolaryngol. 1991 Feb;20(1):27-9.